CJC-1295 10MG NO DAC | Long-Acting Growth Hormone Releasing Hormone Analog

Research with CJC-1295 10mg from THESWISSPEP. A NO-DAC-modified GHRH analog for sustained growth hormone and IGF-1 elevation in studies.

THESWISSPEP CJC-1295 10mg is a modified analog of Growth Hormone-Releasing Hormone (GHRH) with a No Drug Affinity Complex (NO-DAC) attached. This modification allows it to bind to albumin in the bloodstream, creating a sustained release effect that elevates baseline levels of Growth Hormone and IGF-1 over an extended period (several days). It is a key peptide for research requiring prolonged GH exposure.

Key Features & Benefits:

· Sustained Release Profile: The NO-DAC moiety extends half-life significantly, providing a long-acting research effect.

· Elevates Baseline GH/IGF-1: Ideal for studies on the effects of chronically elevated, but pulsatile, GH levels.

· Synergistic with GHRPs: Often researched in combination with Ipamorelin or other secretagogues for amplified effect.

· High-Purity 10mg Vial: Supplied in a standard research quantity for accurate dosing in prolonged studies.

· Ideal For Research Into: Chronic models of GH supplementation, body composition over time, and sleep-related GH secretion.

Specifications:

Product Name: CJC-1295 (NO-DAC)

Quantity: 10mg 

Purity: >99% 

Form: Lyophilized Powder

⚠️ CRITICAL DISCLAIMER FOR ALL PRODUCTS:

These products are sold for LABORATORY RESEARCH USE ONLY by qualified professionals. They are NOT for human or veterinary use, not for consumption, not for injection, and not intended as drugs, cosmetics, or supplements. They must be handled only by trained individuals in appropriate laboratory settings.

THESWISSPEP makes no claims regarding the efficacy or safety of these compounds for any purpose outside of controlled scientific research. Purchaser assumes all responsibility for compliance with local, state, and federal regulations regarding the handling and use of research chemicals.